Post-COVID-19 syndrome: persistent neuroimaging changes and symptoms 9 months after initial infection.

Autor:	Grach SL; Mayo School of Graduate Medical Education, Mayo Clinic, Rochester, Minnesota, USA., Ganesh R; Department of General Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA ganesh.ravindra@mayo.edu., Messina SA; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA., Hurt RT; Department of General Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Jazyk:	angličtina
Zdroj:	BMJ case reports [BMJ Case Rep] 2022 Apr 08; Vol. 15 (4). Date of Electronic Publication: 2022 Apr 08.
DOI:	10.1136/bcr-2021-248448
Abstrakt:	A previously healthy and active middle-aged woman acquired COVID-19 as an occupational exposure with subsequent persistent post-COVID-19 symptoms including headache, dyspnoea on exertion, chest pressure, tachycardia, anosmia, parosmia, persistent myalgia, vertigo, cognitive decline and fatigue. She presented to a tertiary medical centre for further evaluation after 9 months of persistent symptoms and had a largely unremarkable workup with the exception of a persistently elevated monocyte chemoattractant protein 1, blunted cardiovagal response and non-specific scattered areas of low-level hypometabolism at the bilateral frontal, left precuneus, occipital and parietal regions on PET scan. Competing Interests: Competing interests: None declared. (© BMJ Publishing Group Limited 2022. No commercial re-use. See rights and permissions. Published by BMJ.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu